Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
31-40 Round-Up
31-40 Round-Up
31-40 Round-Up
Monday 6th May 2024
Summaries of key studies from Episodes 31-40, covering naloxone training, trazodone for sleep, opioid agonist risks, and more.
63 minutes
Informative
Educational
Supportive
Encouraging
Non-judgmental
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
55 (View all)
Do you want to link to this podcast?
Get the buttons here!Addiction Medicine Journal Club: Episodes 31-40 Round-Up
Episode Overview
- Take-home naloxone training does not increase drug use frequency.
- Trazodone is effective for sleep disturbances in opioid-dependent patients.
- No significant overdose risk when prescribing opioid agonists with other medications.
- Higher buprenorphine doses may be needed in the fentanyl era.
- Removing Medicaid prior authorization can increase buprenorphine treatment uptake.
Giving out Naloxone is not going to make people use more drugs
In this episode of Addiction Medicine Journal Club, Dr. Sonia del Tredici and Dr. John Keenan bring you quick summaries of Episodes 31-40, covering a wide range of topics related to addiction medicine. From the impact of take-home naloxone training on injection drug use frequency to the effectiveness of trazodone for sleep disturbances in opioid-dependent patients, this episode is packed with valuable insights for healthcare professionals.
You'll also hear about the risks associated with prescribing opioid agonists alongside other medications, the best buprenorphine doses in the era of fentanyl, and the effects of removing Medicaid prior authorization requirements on buprenorphine treatment. The episode doesn't stop there; it dives into emotional dysregulation factors linked to problematic smartphone use, and even compares the cost-effectiveness of monthly extended-release buprenorphine versus daily standard care medication.
With detailed discussions on each study, this episode offers a comprehensive overview of the latest research in addiction medicine. Whether you're a busy doctor, PA, or NP, this episode provides a wealth of information to help you stay up-to-date with current practices. Don't miss out on these key findings that could shape your approach to treating addiction.